Conglomerates
Compare Stocks
2 / 10Stock Comparison
IEP vs MS
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
IEP vs MS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Conglomerates | Financial - Capital Markets |
| Market Cap | $5.06B | $307.53B |
| Revenue (TTM) | $9.88B | $103.14B |
| Net Income (TTM) | $-288M | $16.18B |
| Gross Margin | 12.0% | 55.6% |
| Operating Margin | 3.6% | 17.1% |
| Forward P/E | 18.0x | 16.3x |
| Total Debt | $6.62B | $360.49B |
| Cash & Equiv. | $3.42B | $75.74B |
IEP vs MS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Icahn Enterprises L… (IEP) | 100 | 15.9 | -84.1% |
| Morgan Stanley (MS) | 100 | 437.3 | +337.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IEP vs MS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IEP is the clearest fit if your priority is income & stability and sleep-well-at-night.
- Dividend streak 0 yrs, beta 0.60, yield 6.3%
- Lower volatility, beta 0.60, current ratio 4.62x
- Beta 0.60, yield 6.3%, current ratio 4.62x
MS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 16.8%, EPS growth 53.5%
- 7.4% 10Y total return vs IEP's 25.6%
- 16.8% NII/revenue growth vs IEP's -7.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.8% NII/revenue growth vs IEP's -7.5% | |
| Value | Lower P/E (16.3x vs 18.0x) | |
| Quality / Margins | 13.0% margin vs IEP's -2.9% | |
| Stability / Safety | Beta 0.60 vs MS's 1.37, lower leverage | |
| Dividends | 6.3% yield, vs MS's 2.0% | |
| Momentum (1Y) | +66.7% vs IEP's +14.0% | |
| Efficiency (ROA) | 1.2% ROA vs IEP's -1.9%, ROIC 2.9% vs -0.0% |
IEP vs MS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IEP vs MS — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
MS leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
MS is the larger business by revenue, generating $103.1B annually — 10.4x IEP's $9.9B. MS is the more profitable business, keeping 13.0% of every revenue dollar as net income compared to IEP's -2.9%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $9.9B | $103.1B |
| EBITDAEarnings before interest/tax | $954M | $26.3B |
| Net IncomeAfter-tax profit | -$288M | $16.2B |
| Free Cash FlowCash after capex | -$654M | -$6.7B |
| Gross MarginGross profit ÷ Revenue | +12.0% | +55.6% |
| Operating MarginEBIT ÷ Revenue | +3.6% | +17.1% |
| Net MarginNet income ÷ Revenue | -2.9% | +13.0% |
| FCF MarginFCF ÷ Revenue | -6.6% | -2.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.5% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +100.8% | +48.9% |
Valuation Metrics
IEP leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, IEP's 13.8x EV/EBITDA is more attractive than MS's 26.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $5.1B | $307.5B |
| Enterprise ValueMkt cap + debt − cash | $8.3B | $592.3B |
| Trailing P/EPrice ÷ TTM EPS | -15.27x | 24.31x |
| Forward P/EPrice ÷ next-FY EPS est. | 18.05x | 16.28x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.73x |
| EV / EBITDAEnterprise value multiple | 13.76x | 26.03x |
| Price / SalesMarket cap ÷ Revenue | 0.54x | 2.98x |
| Price / BookPrice ÷ Book value/share | 1.33x | 2.95x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
MS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MS delivers a 14.6% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-8 for IEP. IEP carries lower financial leverage with a 1.93x debt-to-equity ratio, signaling a more conservative balance sheet compared to MS's 3.42x. On the Piotroski fundamental quality scale (0–9), MS scores 5/9 vs IEP's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -8.2% | +14.6% |
| ROA (TTM)Return on assets | -1.9% | +1.2% |
| ROICReturn on invested capital | -0.0% | +2.9% |
| ROCEReturn on capital employed | -0.0% | +3.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 |
| Debt / EquityFinancial leverage | 1.93x | 3.42x |
| Net DebtTotal debt minus cash | $3.2B | $284.7B |
| Cash & Equiv.Liquid assets | $3.4B | $75.7B |
| Total DebtShort + long-term debt | $6.6B | $360.5B |
| Interest CoverageEBIT ÷ Interest expense | 0.32x | 0.44x |
Total Returns (Dividends Reinvested)
MS leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MS five years ago would be worth $24,217 today (with dividends reinvested), compared to $5,895 for IEP. Over the past 12 months, MS leads with a +66.7% total return vs IEP's +14.0%. The 3-year compound annual growth rate (CAGR) favors MS at 34.3% vs IEP's -21.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +12.8% | +7.4% |
| 1-Year ReturnPast 12 months | +14.0% | +66.7% |
| 3-Year ReturnCumulative with dividends | -51.0% | +142.1% |
| 5-Year ReturnCumulative with dividends | -41.0% | +142.2% |
| 10-Year ReturnCumulative with dividends | +25.6% | +739.4% |
| CAGR (3Y)Annualised 3-year return | -21.2% | +34.3% |
Risk & Volatility
Evenly matched — IEP and MS each lead in 1 of 2 comparable metrics.
Risk & Volatility
IEP is the less volatile stock with a 0.60 beta — it tends to amplify market swings less than MS's 1.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 99.2% from its 52-week high vs IEP's 79.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.60x | 1.37x |
| 52-Week HighHighest price in past year | $9.99 | $194.83 |
| 52-Week LowLowest price in past year | $7.08 | $117.21 |
| % of 52W HighCurrent price vs 52-week peak | +79.5% | +99.2% |
| RSI (14)Momentum oscillator 0–100 | 69.5 | 61.2 |
| Avg Volume (50D)Average daily shares traded | 952K | 5.4M |
Analyst Outlook
Evenly matched — IEP and MS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates IEP as "Buy" and MS as "Buy". For income investors, IEP offers the higher dividend yield at 6.31% vs MS's 1.97%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | — | $205.75 |
| # AnalystsCovering analysts | 2 | 52 |
| Dividend YieldAnnual dividend ÷ price | +6.3% | +2.0% |
| Dividend StreakConsecutive years of raises | 0 | 11 |
| Dividend / ShareAnnual DPS | $0.50 | $3.81 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.4% |
MS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IEP leads in 1 (Valuation Metrics). 2 tied.
IEP vs MS: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is IEP or MS a better buy right now?
For growth investors, Morgan Stanley (MS) is the stronger pick with 16.
8% revenue growth year-over-year, versus -7. 5% for Icahn Enterprises L. P. (IEP). Morgan Stanley (MS) offers the better valuation at 24. 3x trailing P/E (16. 3x forward), making it the more compelling value choice. Analysts rate Icahn Enterprises L. P. (IEP) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IEP or MS?
On forward P/E, Morgan Stanley is actually cheaper at 16.
3x.
03Which is the better long-term investment — IEP or MS?
Over the past 5 years, Morgan Stanley (MS) delivered a total return of +142.
2%, compared to -41. 0% for Icahn Enterprises L. P. (IEP). Over 10 years, the gap is even starker: MS returned +739. 4% versus IEP's +25. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IEP or MS?
By beta (market sensitivity over 5 years), Icahn Enterprises L.
P. (IEP) is the lower-risk stock at 0. 60β versus Morgan Stanley's 1. 37β — meaning MS is approximately 128% more volatile than IEP relative to the S&P 500. On balance sheet safety, Icahn Enterprises L. P. (IEP) carries a lower debt/equity ratio of 193% versus 3% for Morgan Stanley — giving it more financial flexibility in a downturn.
05Which is growing faster — IEP or MS?
By revenue growth (latest reported year), Morgan Stanley (MS) is pulling ahead at 16.
8% versus -7. 5% for Icahn Enterprises L. P. (IEP). On earnings-per-share growth, the picture is similar: Morgan Stanley grew EPS 53. 5% year-over-year, compared to 44. 7% for Icahn Enterprises L. P.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IEP or MS?
Morgan Stanley (MS) is the more profitable company, earning 13.
0% net margin versus -3. 1% for Icahn Enterprises L. P. — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MS leads at 17. 1% versus -0. 0% for IEP. At the gross margin level — before operating expenses — MS leads at 55. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IEP or MS more undervalued right now?
On forward earnings alone, Morgan Stanley (MS) trades at 16.
3x forward P/E versus 18. 0x for Icahn Enterprises L. P. — 1. 8x cheaper on a one-year earnings basis.
08Which pays a better dividend — IEP or MS?
All stocks in this comparison pay dividends.
Icahn Enterprises L. P. (IEP) offers the highest yield at 6. 3%, versus 2. 0% for Morgan Stanley (MS).
09Is IEP or MS better for a retirement portfolio?
For long-horizon retirement investors, Icahn Enterprises L.
P. (IEP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 60), 6. 3% yield). Both have compounded well over 10 years (IEP: +25. 6%, MS: +739. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IEP and MS?
These companies operate in different sectors (IEP (Industrials) and MS (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IEP is a small-cap income-oriented stock; MS is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.